Diseases, Conditions, Syndromes

Low hep B vaccine response rate linked to IBD treatment

(HealthDay)—For patients with inflammatory bowel disease (IBD), infliximab and/or azathioprine treatment is associated with poor response rate to hepatitis B virus (HBV) vaccination, according to a study published in the ...

Diseases, Conditions, Syndromes

Studies explore racial disparities in IBD symptoms and therapy

Three separate studies presented today at the American College of Gastroenterology's (ACG) 77th Annual Scientific meeting in Las Vegas help to advance understanding of the differences between African American and Caucasian ...

Diseases, Conditions, Syndromes

Drug-induced liver injury is on the rise

More people are being affected by drug-induced liver injury (DILI) than ever before, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. This type of liver injury ...

Diseases, Conditions, Syndromes

IBD patients: Consider giving infliximab a second try

Restarting infliximab therapy after a drug holiday is safe and effective for patients with inflammatory bowel disease (IBD), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice ...

Diseases, Conditions, Syndromes

Predictors of infliximab response in ulcerative colitis identified

(HealthDay)—For patients with acute severe ulcerative colitis (ASUC), the baseline Mayo Endoscopic Score and the C-reactive protein (CRP)/albumin ratio predict treatment response to infliximab, according to research published ...

page 3 from 5